ReviewNew microbes and new infections2025
The burden of dengue fever in travellers: a systematic literature review.
Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dengue and Acute Pancreatitis: A Systematic Review.Tropical medicine and infectious disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dengue is a mosquito-borne viral infection with growing global impact, including international travellers travelling to and from endemic regions. This systematic literature review aimed to assess the clinical and economic burden of dengue in travellers from non-endemic countries. Methods: This systematic review was conducted following the PRISMA guidelines to assess the incidence, prevalence, mortality, healthcare resource use, and costs of dengue fever in travellers between non-endemic and endemic regions. We systematically searched MEDLINE, Embase, Google Scholar, PubMed, and Epistemonikos. Due to heterogeneity, data were synthesised descriptively without quantitative analysis. Results: Seventy unique studies were included. Heterogeneity in design, inconsistent reporting, and lack of denominator data limited the ability to calculate incidence rates or compare risks across regions. Two prospective studies provided incidence rates, reaching 58.7 cases per 1000 person-months of travel. No studies reported prevalence data. With three cases, reported mortality was rare. No cost data were identified, but limited data on healthcare resource use were identified from seven publications. Conclusions: Findings highlight the challenges in quantifying individual risk and the need for improved surveillance, prospective data collection, and targeted prevention strategies. These results support improved travel health guidance and may inform vaccination strategies for travellers to endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.